Science Notebook | Malaria vaccine trials confirm high efficacy, Russia and India sign a new protocol for Kudankulam plant nuclear reactors, and the alarming news that the earth may have already crossed the 1.5°C warming level
MALARIA is the largest cause of death in young African children, and the disease claims over 6,00,000 lives globally each year. Now, results are out of the phase 3 trial data of the R21/Matrix-M⢠malaria vaccine developed by Oxford University and Serum Institute of India. The double-blinded, randomised trials, conducted among 4,800 children in the …